BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Synvista Therapeutics 

221 West Grand Avenue

Montvale  New Jersey  07645  U.S.A.
Phone: 201-934-5000 Fax: 201-934-8880


SEARCH JOBS










 Company News
Synvista Therapeutics Announces Restructuring of Dividend Obligation to Preferred Stockholders and Decision to Delist from NYSE Alternext and Terminate SEC Registration of Common Stock 2/25/2009 8:40:38 AM
Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update 1/29/2009 6:58:05 AM
Synvista Therapeutics Announces Progress in Phase 2 Clinical Trial Program for Alagebrium 1/12/2009 9:36:01 AM
Synvista Therapeutics Notified by NYSE Alternext of Continued Listing Standards Non-Compliance 12/29/2008 10:56:59 AM
Synvista Therapeutics Announces Published Data Demonstrating Elevation of Carboxymethyl-Lysine (CML) Is Associated with Decline in Renal Function and Arterial Stiffness in Older Adults 12/16/2008 8:44:50 AM
Synvista Therapeutics Announces First Dosing of SYI-2074 in Clinical Trial for Psoriasis 12/15/2008 8:05:26 AM
Synvista Therapeutics Announces 510(k) Submission for Its HAPTOCHEK(TM) Test Kit 11/19/2008 8:00:31 AM
Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During American Heart Association Meeting 11/11/2008 9:59:46 AM
Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference 11/10/2008 1:22:14 PM
Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association 11/10/2008 1:14:17 PM
1234